PHARMACOKINETICS OF SECOND LINE ANTI-TB DRUG (LEVOFLOXACIN) IN MDR-TB PATIENTS. scholar. 2019;8(2.2). Accessed March 9, 2025. https://jconsortium.com/index.php/scholar/article/view/93